HK1217654A1 - 作爲激酶抑制劑的呋喃酮化合物 - Google Patents

作爲激酶抑制劑的呋喃酮化合物

Info

Publication number
HK1217654A1
HK1217654A1 HK16105768.1A HK16105768A HK1217654A1 HK 1217654 A1 HK1217654 A1 HK 1217654A1 HK 16105768 A HK16105768 A HK 16105768A HK 1217654 A1 HK1217654 A1 HK 1217654A1
Authority
HK
Hong Kong
Prior art keywords
kinase inhibitors
furanone compounds
furanone
compounds
kinase
Prior art date
Application number
HK16105768.1A
Other languages
English (en)
Inventor
劉東
張民生
Original Assignee
Eternity Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eternity Bioscience Inc filed Critical Eternity Bioscience Inc
Publication of HK1217654A1 publication Critical patent/HK1217654A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16105768.1A 2013-05-08 2016-05-20 作爲激酶抑制劑的呋喃酮化合物 HK1217654A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361820853P 2013-05-08 2013-05-08
PCT/US2014/037247 WO2014182873A1 (en) 2013-05-08 2014-05-08 Furanone compounds as kinase inhibitors

Publications (1)

Publication Number Publication Date
HK1217654A1 true HK1217654A1 (zh) 2017-01-20

Family

ID=51867735

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16105768.1A HK1217654A1 (zh) 2013-05-08 2016-05-20 作爲激酶抑制劑的呋喃酮化合物

Country Status (9)

Country Link
US (1) US9458140B2 (zh)
EP (1) EP2994127B1 (zh)
CN (1) CN105163733B (zh)
AU (1) AU2014262658B2 (zh)
CA (1) CA2909578C (zh)
HK (1) HK1217654A1 (zh)
MX (1) MX2015015290A (zh)
TW (1) TWI634114B (zh)
WO (1) WO2014182873A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019507794A (ja) * 2016-03-10 2019-03-22 ルトリス ファーマ エル ティー ディー． 皮膚反応を治療するためのｂｒａｆ阻害剤の使用
WO2020124397A1 (en) * 2018-12-19 2020-06-25 Inventisbio Shanghai Ltd. C-terminal src kinase inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4606756A (en) * 1984-10-26 1986-08-19 Chevron Research Company Herbicidal 2-(nitrogen heterocycle)5-amino-3-oxo-4-(substituted-phenyl)-2,3-dihydrofurans
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
KR0119908B1 (ko) * 1994-04-18 1997-10-30 강박광 3(2h)-푸란온 유도체
DZ3265A1 (fr) * 1999-04-14 2000-10-19 Pacific Corp Derives de 4,5-diaryl-3(2h)-furanone comme inhibiteurs de cyclo-oxygenase-2
EP2121669A2 (en) * 2007-01-30 2009-11-25 Biogen Idec MA, Inc. Furanone compounds and methods of making and using the same
UA103319C2 (en) * 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
MX2011000175A (es) * 2008-06-25 2011-06-27 Envivo Pharmaceuticals Inc Compuestos heterociclicos 1,2-di-substituidos.
AU2009345802B2 (en) * 2009-05-07 2016-05-26 Forum Pharmaceuticals Inc. Phenoxymethyl heterocyclic compounds
JO3002B1 (ar) * 2009-08-28 2016-09-05 Irm Llc مركبات و تركيبات كمثبطات كيناز بروتين
TW201512201A (zh) * 2013-03-14 2015-04-01 Forum Pharmaceuticals Inc 化合物的多晶型及鹽類

Also Published As

Publication number Publication date
EP2994127A4 (en) 2016-12-14
EP2994127A1 (en) 2016-03-16
TW201506021A (zh) 2015-02-16
US9458140B2 (en) 2016-10-04
US20160096825A1 (en) 2016-04-07
WO2014182873A1 (en) 2014-11-13
TWI634114B (zh) 2018-09-01
CN105163733B (zh) 2019-05-31
MX2015015290A (es) 2016-02-22
CN105163733A (zh) 2015-12-16
AU2014262658B2 (en) 2018-08-02
CA2909578C (en) 2021-07-06
EP2994127B1 (en) 2019-10-09
AU2014262658A1 (en) 2015-11-05
CA2909578A1 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
HRP20181287T1 (hr) Aminoheteroarilbenzamidi kao inhibitori kinaze
ZA201603337B (en) Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
HK1220459A1 (zh) 激酶抑制劑
HK1208442A1 (zh) 作為 激酶抑制劑的取代的吡咯並嘧啶基氨基－苯並噻唑酮
HK1222387A1 (zh) 作為 抑制劑的芳基吡咯並吡啶衍生的化合物
HK1210775A1 (zh) 作為激酶抑制劑的咪唑並三嗪甲腈
HK1211578A1 (zh) 作為 激酶抑制劑的酰氨基咪唑並噠嗪
AP2016009248A0 (en) Apoptosis signal-regulating kinase inhibitors
HK1219104A1 (zh) 激酶抑制劑
EP3007689A4 (en) NON-SELECTIVE KINASE INHIBITORS
IL243295A0 (en) Carbazole carboxamide compounds are useful as kinase inhibitors
SG11201500973WA (en) Amino-quinolines as kinase inhibitors
GB201317609D0 (en) Inhibitor compounds
EP2968331A4 (en) PYRROLOPYRIMIDINE COMPOUNDS AS KINASEINHIBITORS
EP2999472A4 (en) INHIBITORS OF AURORA KINASE
EP2968324A4 (en) SUBSTITUTED PYRIDONE DERIVATIVES AS PDE10 INHIBITORS
HK1217654A1 (zh) 作爲激酶抑制劑的呋喃酮化合物
HK1222386A1 (zh) 作爲詹納斯激酶的抑制劑的 -氰基甲基酰胺
GB201307155D0 (en) Kinase inhibitors
GB201321328D0 (en) Inhibitor compounds
GB201309603D0 (en) Novel compounds and their use as kinase inhibitors
GB201305741D0 (en) Novel compounds and their use as kinase inhibitors